GlobeNewswire Inc.··NaPsyence BioMed Executes Put Option, Issues $5M in Shares to PsyLabs
Psyence BioMed issues $5M in shares to PsyLabs via put option exercise, giving PsyLabs ~50% ownership and strengthening supply chain for psychedelic pharmaceuticals.
PBMPBMWWsupply chainshareholder dilution